{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-044151","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.016843+00:00","generated_at":"2026-05-25T20:12:00.088614+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Kymera grants PSUs to key employees with three clinical milestone vesting targets","bullets":["PSUs vest in three installments: 40% for first milestone, 40% for second, 20% for third.","No PSUs vest before first anniversary of grant date; total payout ranges 0-100% of target.","Grants approved March 3, 2025 under 2020 Stock Plan for named executive officers and management.","Target number of PSUs not disclosed; full award terms to be filed in Q1 2025 10-Q."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-044151","json":"https://secwatch.observer/filing/0001193125-25-044151.json","markdown":"https://secwatch.observer/filing/0001193125-25-044151.md","text":"https://secwatch.observer/filing/0001193125-25-044151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/0001193125-25-044151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/d940925d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T20:12:00.088614+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}